Cutler Group’s CareDx CDNA Stock Holding History

Cutler Group’s Portfolio CDNA Stock Details CDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-500	Closed	-$2K	–	5021
2022 Q1	$2K	Buy	+500	New	+$19.5K	﹤0.01%	4627
2019 Q3	–	Sell	-100	Closed	-$1K	–	4116
2019 Q2	$1K	Buy	+100	New	+$3.2K	﹤0.01%	3794

Other funds holding CDNA

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Cutler Group's CDNA Position: Q2 2022 in Review

Cutler Group sold out of CareDx (CDNA) in Q2 2022, closing a stake of 100 shares — an estimated $2.77K sold.

Cutler Group first reported a position in CDNA in Q3 2018 and held it in 9 quarters. The position peaked at $44K in Q1 2019. 184 funds tracked by Wall St. Rank hold CDNA as of Q2 2022.

Cutler Group reported no remaining CareDx position as of Q2 2022 after selling out during the quarter.
Cutler Group sold 100 CareDx shares in Q2 2022, an estimated $2.77K.
Cutler Group first reported a position in CareDx in Q3 2018 and held it in 9 quarters.
Cutler Group's CareDx position peaked at $44K in Q1 2019.
184 funds tracked by Wall St. Rank held CareDx as of Q2 2022.

Based on Cutler Group's 13F filing for Q2 2022, filed 4 Aug 2022.